Navigation Links
Morse CyberKnife CEO James G. Schwade, M.D. Announces Non-Surgical Treatment With CyberKnife Radiosurgery for Prostate Cancer
Date:9/2/2008

September is Prostate Cancer Awareness Month

MIAMI and PALM BEACH, Fla., Sept. 2 /PRNewswire/ -- September is Prostate Cancer Awareness Month, and the CyberKnife Centers of Miami and Palm Beach announce a revolutionary new way to treat prostate cancer without surgery and long treatment courses of radiation. Prostate cancer is the most common form of cancer affecting men in the US.

Morse CyberKnife CEO, James G. Schwade, M.D., says, "for many cases that are diagnosed early on, CyberKnife radiosurgery may be highly effective without invasive, debilitating surgery or long courses of radiation."

CyberKnife is image guided robotic radiosurgery that precisely targets a lesion or tumor and delivers an intense dose of radiation to a very small area killing the cancer cells within.
The CyberKnife treats prostate cancer in the following manner:

-- Outpatient status

-- Non-invasive

-- Less pain and side effect than most alternatives

-- Complete treatment in 3-5 visits, each usually no longer than 1.5 hrs

-- Minimum radiation to surrounding normal areas

It is the mission of the Morse CyberKnife Centers to make the technology an option available to all cancer patients who might benefit. For more information please visit http://www.morsecyberknife.com or call 1-800-279-2900.


'/>"/>
SOURCE Morse CyberKnife
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. M. D. Anderson Cancer Center to Lead Study of Surgery vs. CyberKnife(R) Radiosurgery for Operable Lung Cancer Patients
2. New CyberKnife Technologies Demonstrate Dramatic Reduction in Treatment Times
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)...  Impax Laboratories, Inc. (NASDAQ: IPXL ) today announced that ... Raymond James and Associates, 38 th Annual ... Orlando, FL. Cowen and Company ... March 7, 2017 in Boston, MA. ... in Miami, FL. Individuals ...
(Date:2/27/2017)... February 27, 2017 Leading Countries, Technologies and ... is expected to grow at a CAGR of 8.9% from 2016-2021 ... grow at a CAGR of 9.1% from 2016 to 2027. The ... ... will benefit you Read on to discover how you can ...
(Date:2/27/2017)... – December 2016 Revenues amounted to SEK 0.3 (0.1) ... Result after tax amounted to SEK -16.3 (-6.5) million, corresponding to ... flow from operating activities amounted to SEK -8.3 (-7.3) million ... Period full year 2016 ... to SEK -39.5 (-29.5) million Result after tax amounted to ...
Breaking Medicine Technology:
(Date:2/27/2017)... San Francisco, CA (PRWEB) , ... February 27, ... ... Area center for hair transplantation therapy, is proud to announce a new informational ... popular hair therapy procedures. Follicular Unit Extraction (FUE) hair transplant and Follicular Unit ...
(Date:2/26/2017)... ... February 26, 2017 , ... Today, A' Design ... Edition of International Social Design Awards. , The 7th A' Social Design ... Governments and Institutions worldwide with realized projects and conceptual works. , The first ...
(Date:2/26/2017)... ... February 26, 2017 , ... IndustryArchive.Org . is announcing a ... Marketing. B2B Sellers will now only pay for B.A.N.T. quality sales leads based on ... IndustryArchive.Org, said, “Given the new reality that B2B buyers are controlling the sales process ...
(Date:2/26/2017)... Miami, Florida (PRWEB) , ... February 26, 2017 ... ... risk of Parkinson’s disease (PD) in persons with a specific LRRK2 mutation, according ... Disorders Congress. , Previous studies have provided evidence of a link between pesticides ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the official ... (ILTM) show in Cannes (France), XO Private has initiated a second print-run of its ... measures almost a metre across when open, weighs in at more than six kilos, ...
Breaking Medicine News(10 mins):